A new, experimental skin cancer vaccine by the US company Moderna has had positive results in a late-stage trial.
[Subscribe to our Substack newsletter: https://channel4news.substack.com/subscribe]
The mRNA vaccine, given to patients already diagnosed with melanoma, was given in conjunction with an immunotherapy drug and was shown to reduce the spread and recurrence of melanoma.
It boosted the share price of Moderna - famous for its COVID vaccine - by as much as 93%.
#News #Channel4News #C4News #Vaccine #Cancer #Health
-------
Get more news at our site - https://www.channel4.com/news/
Subscribe to our Substack newsletter: https://channel4news.substack.com/subscribe
Follow us:
TikTok - https://www.tiktok.com/@c4news
Instagram - https://www.instagram.com/channel4news/
Twitter - https://twitter.com/Channel4News
Facebook - https://www.facebook.com/Channel4News/